Patents by Inventor Brian Doan

Brian Doan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230290483
    Abstract: A system for providing disability-tailored therapy to a user having a disability with a presentation of the disability-tailored therapy compliant with accessibility requirements such that the presentation is accessible to the user having the disability is provided. The system includes a memory, a processor coupled to the memory programed with executable instructions, and a user device. The executable instructions cause the processor to obtain a disability-tailored therapy session for the user having the disability based on the disability. The user device configured to receive an input form the user and present the disability-tailored therapy session. The input is user information comprising the disability. The presentation is configured to be accessible to the user having the disability.
    Type: Application
    Filed: March 7, 2023
    Publication date: September 14, 2023
    Inventors: Laura Randa, Brian Doan
  • Patent number: 11399575
    Abstract: Embodiments can provide a wearable device for nicotine cessation behavioral support, comprising a top surface; a first surface; a second surface; an underside surface; a communication device; one or more buttons; an internal storage medium; and a power supply; wherein the one or more buttons are configured to log a NRT use event to the internal storage medium when depressed and subsequently released within a predetermined timeframe; wherein the one or more buttons are configured to log a tobacco use event to the internal storage medium when depressed and released at a time longer than the predetermined timeframe; wherein the one or more buttons, when depressed, are configured to log a craving event to the internal storage medium, wherein an intensity of the craving event is determined by a time duration between depression and release of the one or more buttons.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: August 2, 2022
    Assignee: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Publication number: 20190037919
    Abstract: Embodiments can provide a wearable device for nicotine cessation behavioral support, comprising a top surface; a first surface; a second surface; an underside surface; a communication device; one or more buttons; an internal storage medium; and a power supply; wherein the one or more buttons are configured to log a NRT use event to the internal storage medium when depressed and subsequently released within a predetermined timeframe; wherein the one or more buttons are configured to log a tobacco use event to the internal storage medium when depressed and released at a time longer than the predetermined timeframe; wherein the one or more buttons, when depressed, are configured to log a craving event to the internal storage medium, wherein an intensity of the craving event is determined by a time duration between depression and release of the one or more buttons.
    Type: Application
    Filed: June 7, 2018
    Publication date: February 7, 2019
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Publication number: 20150286075
    Abstract: Described herein is an apparatus and method for characterizing the precise dimensions of a pair of eyeglass frames, including that of the internal setting groove, through a non-mechanical measurement mechanism. The intended spatial resolution in all three orthogonal axes (x, y, & z) is better than 50 microns (millionths of a meter).
    Type: Application
    Filed: April 8, 2014
    Publication date: October 8, 2015
    Applicant: MANAGING INNOVATION AND TECHNOLOGY
    Inventors: Hoa Nguyen, George Deprez, Sameer Cholayil, Ted Roepsch, James Holbrook, Brian Doan, Jorge Bermeo
  • Publication number: 20050261507
    Abstract: The present invention provides processes and compounds that are useful in the preparation of (3?,3a?,6ahexahydrofuro[2,3-b]furan-3-ol and diastereoisomers thereof, which are useful in the preparation of compounds that may be inhibitors of HIV aspartyl protease.
    Type: Application
    Filed: June 25, 2003
    Publication date: November 24, 2005
    Inventors: Brian Doan, Daniel Patterson, John Roberts
  • Patent number: D842719
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: March 12, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D842720
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: March 12, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D854542
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: July 23, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton
  • Patent number: D868780
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: December 3, 2019
    Assignee: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Inventors: Brian Doan, Jeffrey Brunner, Alexander James Peacop, Martin Crofton